The world's largest food company has launched a new 'Ozempic-friendly' range for those who take the weight management drug.
Ozempic is just one of a range of what are called GLP-1 drugs; a class of medications that mainly help manage blood sugar levels for those with Type 2 diabetes.
But it is also used to help those struggling with obesity, with the likes of Ozempic, Wegovy, and Mounjaro suppressing your appetite and increasing the amount of time food stays in the stomach, leading to weight loss.
Advert
Now, food giant Nestle is offering food products for people on GLP-1 drugs to aid their weight loss journeys.
The company says the products 'are high in protein, a good source of fibre, contain essential nutrients, and they are portion-aligned to a weight loss medication user's appetite'.
Called Vital Pursuit, the line of food products will be available in the USA.
Advert
Steve Presley, Chief Executive Officer at Nestle North America, said: "At Nestlé we want to be there for every moment in our consumers' lives - today and in the future.
"As the use of medications to support weight loss continues to rise, we see an opportunity to serve those consumers.
"Vital Pursuit provides accessible, great-tasting food options that support the needs of consumers in this emerging category.
"We're leveraging our deep understanding of consumers and nutritional science to stay ahead of the trends that are shaping consumer behaviours, and innovating across our portfolio to deliver products people will love."
Advert
Nestle says the GLP-1 friendly foods will be available in the final quarter of 2024.
It comes as one doctor with millions of TikTok followers revealed 'the truth' about taking GLP-1 drugs like Ozempic when it comes to wanting to lose weight.
Dr. Karan Rajan explained when the time is right to take the drug and when it should be avoided due to risks that exist with consuming the medication regularly.
Advert
Dr Rajan said: "Research shows that most people who stop Ozempic will regain most of their original weight. This study of almost 2,000 adults showed that patients how stopped ozempic regained two thirds of the lost weight within a year.
"The question then becomes do you actually need to chase weight loss at all cost, or at the cost of taking medications for life? And the answer to that might be yes if the alternative is life-threatening chronic metabolic diseases."
He continued: "For the select group of patients who would benefit from Ozempic it's got a far lower risk profile than major weight loss surgery which literally involves rearranging your guts.
Advert
"And it can still offer similar weight loss benefits and be far less invasive. In specific cases, Ozempic can be a game-changer for the treatment of obesity. But for someone who is slightly overweight or a normal weight, and taking Ozempic to shed a few kilos or get that summer six pack, the risk-benefit ratio of Ozempic does not land favourably.
"To get a six pack are you willing to risk a side effect like pancreatitis, the inflammation of the pancreas that can be fatal. Ultimately the data shows Ozempic alone is not sufficient for sustainable long term weight loss. It has to be combined with lifestyle changes including dietary changes and exercise."
Topics: Food And Drink, Health, US News, World News, Science
Tom Earnshaw